US Patent Application 20090285901 - Polyamino acid for use as adjuvant
InventorsUS Classes424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/204.1, Virus or component thereof424/207.1, Retroviridae (e.g., feline leukemia virus, bovine leukemia virus, avian leukosis virus, equine infectious anemia virus, Rous sarcoma virus, HTLV-I, etc.)424/208.1, Immunodeficiency virus (e.g., HIV, etc.)424/209.1, Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.)424/218.1, Togaviridae or Flaviviridae, except hepatitis C virus (e.g., yellow fever virus, bovine viral diarrhea virus, dengue virus, equine viral arteritis virus, equine encephalitis virus, Japanese B encephalitis virus, Sindbis virus, flavivirus, etc.)424/221.1Coronaviridae (e.g., neonatal calf diarrhea virus, feline infectious peritonitis virus, canine coronavirus, etc.)Attorney, Agent or FirmForeign Documents
International ClassesA61K 39/21A61K 9/14 A61K 39/12 A61P 31/12 A61K 39/145 A61P 31/18 Issued Patent Number:8017154Abstract textUse of a polyamino acid as an adjuvant; an application of a polyamino acid as an adjuvant in the production of a vaccine; a vaccine comprising a polyamino acid as an adjuvant; a biodegradable nanoparticle having a virus antigen immobilized thereon; and a vaccine comprising the biodegradable nanoparticle. |
| ||||||||||||||
